Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP181624.RASkI-NlMHBzqI_ASetSLtio-tIV2k4bmmtx_MvkHLdYo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP181624.RASkI-NlMHBzqI_ASetSLtio-tIV2k4bmmtx_MvkHLdYo130_assertion type Assertion NP181624.RASkI-NlMHBzqI_ASetSLtio-tIV2k4bmmtx_MvkHLdYo130_head.
- NP181624.RASkI-NlMHBzqI_ASetSLtio-tIV2k4bmmtx_MvkHLdYo130_assertion wasGeneratedBy ECO_0000203 NP181624.RASkI-NlMHBzqI_ASetSLtio-tIV2k4bmmtx_MvkHLdYo130_provenance.
- NP181624.RASkI-NlMHBzqI_ASetSLtio-tIV2k4bmmtx_MvkHLdYo130_assertion wasDerivedFrom lhgdn-20090331 NP181624.RASkI-NlMHBzqI_ASetSLtio-tIV2k4bmmtx_MvkHLdYo130_provenance.
- NP181624.RASkI-NlMHBzqI_ASetSLtio-tIV2k4bmmtx_MvkHLdYo130_assertion SIO_000772 18027257 NP181624.RASkI-NlMHBzqI_ASetSLtio-tIV2k4bmmtx_MvkHLdYo130_provenance.
- NP181624.RASkI-NlMHBzqI_ASetSLtio-tIV2k4bmmtx_MvkHLdYo130_assertion evidence source_evidence_literature NP181624.RASkI-NlMHBzqI_ASetSLtio-tIV2k4bmmtx_MvkHLdYo130_provenance.
- NP181624.RASkI-NlMHBzqI_ASetSLtio-tIV2k4bmmtx_MvkHLdYo130_assertion description "[The CDKIs p16 and p27 are associated with tumour progression in melanoma, but do not reliably predict recurrence or survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181624.RASkI-NlMHBzqI_ASetSLtio-tIV2k4bmmtx_MvkHLdYo130_provenance.